Launch forecasts under pressure.
New product launches falling short of two-year sales forecasts.
ORSYNC synchronizes people, data, purpose—turning subtle signals into decisions with measurable impact. From pharmaceutical medico-marketing and sales management to drug discovery and development, we connect intelligence around the outcomes that matter.
ORSYNC aligns fragmented evidence and human expertise into an integrated intelligence ecosystem—connecting near-term priorities with bold, long-term ambitions and better patient outcomes.
New product launches falling short of two-year sales forecasts.
Estimated annual waste linked to expired or obsolete pharmaceutical products and forecasting challenges.
Campaign spend estimated to miss expected ROI—equivalent to approximately $2B in annual waste.
From innovative pharmaceutical solutions to measurable healthcare impact, our ambition is to align people, data and purpose through intelligent systems.
Through well-developed innovative portfolio, ORSYNC is going to be redefining the pharmaceuticals from MM&S management to drug discovery & development by seamlessly integrating ai and automation solutions to get people, data & purpose well-synchronized for value integration & operational excellence, accelerated digital transformation & global scalability to enhance the healthcare impact & patient outcomes.
One integrated intelligence ecosystem. Three focused products aligning data, expertise and purpose for more impactful decisions.
Analyze and strategize without losing context. Bring market, customer, competitor and regulatory evidence together so teams can identify patterns, pressure-test assumptions and move from insight to clear decisions.
Validate campaign fit and optimize the impact before committing budget. Connect evidence, HCP segmentation and execution assumptions to compare scenarios, guide allocation and support measurable campaign decisions.
A reviewer-led pharmacovigilance workspace for triage, coding decisions, causality support and draft regulatory preparation. The system organizes evidence and surfaces priorities; qualified reviewers retain decision authority.
Connected solutions across strategic intelligence, commercial execution and drug safety—built around the decisions that matter.
Bring market dynamics, competitive signals and research evidence into a connected strategic view.
Link audience fit, campaign evidence and investment choices to stronger planning conversations.
Equip safety reviewers with a clearer view of cases, signals and draft-readiness gaps.
Artificial intelligence can accelerate analysis. Confidence still depends on traceable evidence, explicit uncertainty and professionals who can challenge the output.
Keep sources and assumptions visible. Separate observed evidence from interpretation, and make gaps explicit.
Support expert decisions with structured evidence and reviewable outputs—without claiming regulatory authority.
Start with real professional questions: what changed, why, what options exist and who must decide?
Treat privacy, access and deployment boundaries as design requirements, to be verified for each environment.
CONTACT ORSYNCcontactus@orsync.online
See patterns
before others.